Press releases

Space travel has long fascinated humanity, but it also poses significant health risks, particularly to the brain and muscles. The...

Sachi Bio won Phase IIE and Phase III contracts from the NASA Human Research Program to continue advancement of the Neurotherapeutic...

Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...

Multiple sclerosis (MS) is a serious autoimmune disease that affects millions of people worldwide, with women being four times more...

Neuroinflammation, or inflammation in the brain, plays a significant role in many neurodegenerative diseases. These diseases, which...

"Sachi Bio has successfully advanced it's lead program towards translation for a range of neurodegenerative diseases, as well as a...

Starting in 2030, we will witness a historic milestone as the elderly population surpasses the youth for the first time ever. This...

Sachi Bio is sending samples to International Space Station (ISS) Labs to study the effect of microgravity on brain aging and disease...